Evaluation of the obesity genes FTO and MC4R and the type 2 diabetes mellitus gene TCF7L2 for contribution to stroke risk: The Mannheim-Heidelberg stroke study

Obesity Facts

Volumn 4, Issue 4, 2011, Pages 290-296

  Winter, Yaroslav ^a   Back, Tobias ^b   Scherag, André ^c   Linseisen, Jakob ^d,e   Rohrmann, Sabine ^d   Lanczik, Oliver ^f   Hinney, Anke ^c   Scherag, Susann ^c   Neumaier, Michael ^g   Ringleb, Peter A ^f   Dodel, Richard ^a   Hebebrand, Johannes ^c  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

^b Saxon Hospital Arnsdorf   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^e INSTITUTE OF EPIDEMIOLOGY   (Germany)

^f UNIVERSITY OF HEIDELBERG   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

FTO; Genetics; MC4R; Obesity genes; Stroke; TCF7L2

Indexed keywords

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; EVALUATION; FEMALE; FTO GENE; GENE; GENETIC MARKER; GENETIC PREDISPOSITION; HUMAN; MAJOR CLINICAL STUDY; MALE; MC4R GENE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; STROKE; TCF7L2 GENE; TRANSIENT ISCHEMIC ATTACK;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; GENETIC MARKERS; HUMANS; ISCHEMIC ATTACK, TRANSIENT; MALE; MIDDLE AGED; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RECEPTOR, MELANOCORTIN, TYPE 4; RISK FACTORS; STROKE; TRANSCRIPTION FACTOR 7-LIKE 2 PROTEIN;

EID: 80053021844     PISSN: 16624025     EISSN: 16624033     Source Type: Journal    
DOI: 10.1159/000330881     Document Type: Article

References (43)

1. Winter Y, Wolfram C, Schaeg M, Reese JP, Oertel WH, Dodel R, Back T: Evaluation of costs and outcome in cardioembolic stroke or TIA. J Neurol 2009;256:954-963.
2. Winter Y, Wolfram C, Schöffski O, Dodel RC, Back T: Long-term disease-related costs 4 years after stroke or TIA in Germany (in German). Nervenarzt 2008;79:918-926.
3. Epifanov Y, Dodel R, Haacke C, Schaeg M, Schoeffski O, Hennerici M, Back T: Costs of acute stroke care on regular neurological wards: a comparison with stroke unit setting. Health Policy 2007;81:339-349. (Pubitemid 46436191)
4. Back T, Schaeg M, Back C, Epifanov Y, Hemmen T, Dodel RC, Schoffski O: Costs of stroke unit care in Germany. Resource use and reimbursements by German diagnosis related groups (in German). Nervenarzt 2004;75:991-999. (Pubitemid 39468511)
5. Dodel R, Winter Y, Ringel F, Spottke A, Gharevi N, Muller I, Klockgether T, Schramm J, Urbach H, Meyer B: Cost of illness in subarachnoid hemorrhage. A German longitudinal study. Stroke 2010;41:2918-2923.
6. Suk SH, Sacco RL, Boden-Albala B, Cheun JF, Pittman JG, Elkind MS, Paik MC: Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003;34:1586-1592. (Pubitemid 36842606)
7. Hu G, Tuomilehto J, Silventoinen K, Sarti C, Mannisto S, Jousilahti P: Body mass index, waist circumference, and waist-hip ratio on the risk of total and type-specific stroke. Arch Intern Med 2007;167:1420-1427. (Pubitemid 47052442)
8. Winter Y, Rohrmann S, Linseisen J, Lanczik O, Ringleb PA, Hebebrand J, Back T: Contribution of obesity and abdominal fat mass to risk of stroke and transient ischemic attacks. Stroke 2008;39:3145-3151.
9. Dichgans M: Genetics of ischaemic stroke. Lancet Neurol 2007;6:149-161. (Pubitemid 46097541)
10. Casas JP, Hingorani AD, Bautista LE, Sharma P: Meta-analysis of genetic studies in ischemic stroke: thirty-two genes involving approximately 18, 000 cases and 58, 000 controls. Arch Neurol 2004;61:1652-1661. (Pubitemid 39463422)
11. Lee BC, Lee HJ, Chung JH: Peroxisome proliferatoractivated receptor-gamma2 Pro12Ala polymorphism is associated with reduced risk for ischemic stroke with type 2 diabetes. Neurosci Lett 2006;410:141-145. (Pubitemid 44709410)
12. Zafarmand MH, van der Schouw YT, Grobbee DE, de Leeuw PW, Bots ML: Peroxisome proliferatoractivated receptor gamma-2 P12A polymorphism and risk of acute myocardial infarction, coronary heart disease and ischemic stroke: a casecohort study and meta-analyses. Vasc Health Risk Manag 2008;4:427-436. (Pubitemid 351711971)
13. Hermann S, Rohrmann S, Linseisen J: Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control 2009;20:1397-1408.
14. WHO MONICA Project Principal Investigators: The World Health Organization MONICA Project (monitoring trends in cardiovascular disease): a major international collaboration. J Clin Epidemiol 1988;41:105-114.
15. Rankin J: Cerebral vascular accidents in patients over the age of 60. Scott Med J 1957;2:200-215.
16. Brott T, Adams HP Jr, Olinger CP, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 1989;20:864-870. (Pubitemid 19188240)
17. Loos RJ, Lindgren CM, Li S,: Common variants near MC4R are associated with fat mass, weight and risk of obesity. Nat Genet 2008;40:768-775. (Pubitemid 351748863)
18. Geller F, Reichwald K, Dempfle A, Illig T, Vollmert C, Herpertz S, Siffert W, Platzer M, Hess C, Gudermann T, Biebermann H, Wichmann HE, Schafer H, Hinney A, Hebebrand J: Melanocortin-4 receptor gene variant I103 is negatively associated with obesity. Am J Hum Genet 2004;74:572-581. (Pubitemid 38325928)
19. Frayling TM, Timpson NJ, Weedon MN, et al: A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 2007;316:889-894. (Pubitemid 46764279)
20. Grant SF, Thorleifsson G, Reynisdottir I, et al: Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes. Nat Genet 2006;38:320-323.
21. Chambers JC, Elliott P, Zabaneh D, Zhang W, Li Y, Froguel P, Balding D, Scott J, Kooner JS: Common genetic variation near MC4R is associated with waist circumference and insulin resistance. Nat Genet 2008;40:716-718. (Pubitemid 351748872)
22. Helgason A, Pálsson S, Thorleifsson G, et al: Refining the impact of TCF7L2 gene variants on type 2 diabetes and adaptive evolution. Nat Genet 2007;39:218-225. (Pubitemid 46184353)
23. Sousa AG, Marquezine GF, Lemos PA, Martinez E, Lopes N, Hueb WA, Krieger JE, Pereira AC: TCF7L2 polymorphism rs7903146 is associated with coronary artery disease severity and mortality. PloS One 2009;4(11):e7697.
24. Muller TD, Hinney A, Scherag A, Nguyen TT, Schreiner F, Schafer H, Hebebrand J, Roth CL, Reinehr T: 'Fat mass and obesity associated' gene (FTO): no significant association of variant rs9939609 with weight loss in a lifestyle intervention and lipid metabolism markers in German obese children and adolescents. BMC Med Genet 2008;9:85.
25. Roth CL, Hinney A, Reinehr T, Schreiner F, Nguyen TT, Muller T, Scholl C, Woelfle J, Karpushova A, Schafer H, Nothen MM, Hebebrand J: TCF7L2 polymorphism rs7903146 and predisposition for type 2 diabetes mellitus in obese children. Horm Metab Res 2008;40:713-717.
26. Gotoda T, Scott J, Aitman TJ: Molecular screening of the human melanocortin-4 receptor gene: identification of a missense variant showing no association with obesity, plasma glucose, or insulin. Diabetologia 1997;40:976-979. (Pubitemid 27316581)
27. Yusuf S, Hawken S, Ôunpuu S, Bautista L, Franzosi MG, Commerford P, Lang CC, Rumboldt Z, Onen CL, Lisheng L, Tanomsup S, Wangai JP, Razak F, Sharma AM, Anand SS, on behalf of the INTERHEART Study Investigators: Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet 2005;366:1640-1649. (Pubitemid 41552419)
28. Dempfle A, Hinney A, Heinzel-Gutenbrunner M, Raab M, Geller F, Gudermann T, Schafer H, Hebebrand J: Large quantitative effect of melanocortin-4receptor gene mutations on body mass index. J Med Genet 2004;41:795-800. (Pubitemid 39389299)
29. Heid IM, Vollmert C, Kronenberg F, Huth C, Ankerst DP, Luchner A, Hinney A, Bronner G, Wichmann HE, Illig T, Doring A, Hebebrand J: Association of the MC4R V103I polymorphism with the metabolic syndrome: the KORA Study. Obesity (Silver Spring) 2008;16:369-376. (Pubitemid 351271918)
30. Al-Attar SA, Pollex RL, Ban MR, Young TK, Bjerregaard P, Anand SS, Yusuf S, Zinman B, Harris SB, Hanley AJ, Connelly PW, Huff MW, Hegele RA: Association between the FTO rs9939609 polymorphism and the metabolic syndrome in a non-Caucasian multi-ethnic sample. Cardiovasc Diabetol 2008;7:5.
31. Kivimaki M, Smith GD, Timpson NJ, Lawlor DA, Batty GD, Kahonen M, Juonala M, Ronnemaa T, Viikari JS, Lehtimaki T, Raitakari OT: Lifetime body mass index and later atherosclerosis risk in young adults: examining causal links using Mendelian randomization in the Cardiovascular Risk in Young Finns study. Eur Heart J 2008;29:2552-2560.
32. Groves CJ, Zeggini E, Minton J, Frayling TM, Weedon MN, Rayner NW, Hitman GA, Walker M, Wiltshire S, Hattersley AT, McCarthy MI: Association analysis of 6, 736 U. K. subjects provides replication and confirms TCF7L2 as a type 2 diabetes susceptibility gene with a substantial effect on individual risk. Diabetes 2006;55:2640-2644. (Pubitemid 44871167)
33. Cauchi S, El Achhab Y, Choquet H, Dina C, Krempler F, Weitgasser R, Nejjari C, Patsch W, Chikri M, Meyre D, Froguel P: TCF7L2 is reproducibly associated with type 2 diabetes in various ethnic groups: a global meta-analysis. J Mol Med (Berl) 2007;85:777-782. (Pubitemid 47063530)
34. Bielinski SJ, Pankow JS, Folsom AR, North KE, Boerwinkle E: TCF7L2 single nucleotide polymorphisms, cardiovascular disease and all-cause mortality: the Atherosclerosis Risk in Communities (ARIC) study. Diabetologia 2008;51:968-970.
35. Gromadzka G, Sarzynska-Dlugosz I, Czlonkowska A: IL1RN intron 2 polymorphism caused by variable number tandem repeats is associated with 1-year outcome in patients with ischaemic stroke. J Neurol Neurosurg Psychiatry 2007;78:183-186. (Pubitemid 46220219)
36. Greisenegger S, Endler G, Haering D, Schillinger M, Lang W, Lalouschek W, Mannhalter C: The (-174) G/C polymorphism in the interleukin-6 gene is associated with the severity of acute cerebrovascular events. Thromb Res 2003;110:181-186. (Pubitemid 37338290)
37. van Rijn MJ, Slooter AJ, Bos MJ, Catarino CF, Koudstaal PJ, Hofman A, Breteler MM, van Duijn CM: Insulin-like growth factor I promoter polymorphism, risk of stroke, and survival after stroke: the Rotterdam study. J Neurol Neurosurg Psychiatry 2006;77:24-27. (Pubitemid 43022685)
38. Ramoni RB, Himes BE, Sale MM, Furie KL, Ramoni MF: Predictive genomics of cardioembolic stroke. Stroke 2009;40(3 suppl):S67-70.
39. Kruyt ND, Biessels GJ, Devries JH, Roos YB: Hyperglycemia in acute ischemic stroke: pathophysiology and clinical management. Nat Rev Neurol 2010;6:145-155.
40. Sie MP, Uitterlinden AG, Bos MJ, Arp PP, Breteler MM, Koudstaal PJ, Pols HA, Hofman A, van Duijn CM, Witteman JC: TGF-beta 1 polymorphisms and risk of myocardial infarction and stroke: the Rotterdam Study. Stroke 2006;37:2667-2671. (Pubitemid 44922523)
41. MacClellan LR, Howard TD, Cole JW, Stine OC, Giles WH, O'Connell JR, Wozniak MA, Stern BJ, Mitchell BD, Kittner SJ: Relation of candidate genes that encode for endothelial function to migraine and stroke: the Stroke Prevention in Young Women study. Stroke 2009;40(10):e550-557.
42. Speliotes EK, Willer CJ, Berndt SI, et al: Association analyses of 249, 796 individuals reveal 18 new loci associated with body mass index. Nat Genet 2010;42:937-948.
43. Heid IM, Jackson AU, Randall JC, et al: Metaanalysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution. Nat Genet 2010;42:949-960.